Establishment and characterization of a spontaneously immortalized myofibroblast cell line derived from a human liver angiosarcoma

Journal of Hepatology

Volumn 33, Issue 2, 2000, Pages 290-300

  Boivin Angele, Sandra ^a   Pedron, Sandrine ^a   Bertrand, Suzanne ^b   Desmouliere, Alexis ^c   Martel Planche, Ghyslaine ^d   Lefrançois, Lydie ^a   Bancel, Brigitte ^e   Trépo, Christian ^a   Marion, Marie Jeanne ^a  

^a INSERM   (France)

^b CENTRE LÉON BÉRARD   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e CROIX ROUSSE HOSPITAL   (France)

Author keywords

Angiosarcoma; Fibrosis; Liver; Myofibroblasts; P53 gene; Stellate cells

Indexed keywords

ALPHA ACTIN; CYTOKERATIN 19; DESMIN; FIBRONECTIN; MYOSIN; PROTEIN P53; VIMENTIN; VON WILLEBRAND FACTOR;

ANGIOSARCOMA; ARTICLE; CELL ULTRASTRUCTURE; CHROMOSOME NUMBER; EXPLANT; FIBROSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LIVER CARCINOGENESIS; LIVER SARCOMA; MISSENSE MUTATION; MYOFIBROBLAST; ONCOGENE RAS; PRIORITY JOURNAL; STELLATE CELL;

EID: 0033940581     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80370-0     Document Type: Article

References (40)

1. Grobstein C. Mechanisms of organogenetic tissue interaction. Natl Cancer Inst Monogr. 26:1967;279-299.
2. Chung LW. The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv. 23:1995;33-42.
3. Horgan K, Jones DL, Mansel RE. Mitogenicity of human fibroblasts in vivo for human breast cancer cells. Br J Surg. 74:1987;227-229.
4. Hornby AE, Cullen KJ. Mammary tumor fibroblasts are phenotypically distinct from non-tumor fibroblasts. EXS. 74:1995;249-271.
5. Kaczynski J, Hansson G, Wallerstedt S. Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer. 73:1996;128-132.
6. Popper H, Thomas LB, Telles NC, Falk H, Selikoff IJ. Development of hepatic angiosarcoma in man induced by vinyl chloride, Thorotrast, and arsenic. Am J Pathol. 92:1978;349-369.
7. Friedman S L. Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol. 32:1997;424-430.
8. Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver. 18:1998;2-13.
9. Desmouliere A, Gabbiani G. The role of myofibroblast in wound healing and fibrocontractive diseases. Clark RAF. 1996;391-423 Plenum Publishing Corporation, New York.
10. Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, et al. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology. 26:1997;1458-1466.
11. Tran Van Nhieu J, Brocheriou I, Preaux AM, Mallat A, Cherqui D, Zafrani ES, et al. Myofibroblasts and hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol. 29:1998;120-128.
12. Murakami K, Abe T, Miyazawa M, Yamaguchi M, Masuda T, Matsuura T, et al. Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. Lab Invest. 72:1995;731-739.
13. Weill FX, Blazejewski S, Blanc JF, Huet S, Gauthier J M, Neaud V, et al. Characterization of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor beta 1. Lab Invest. 77:1997;63-70.
14. Benzonana G, Skalli O, Gabbiani G. Correlation between the distribution of smooth muscle or non muscle myosins and alpha-smooth muscle actin in normal and pathological soft tissues. Cell Motil Cytoskeleton. 11:1988;260-274.
15. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 103:1986;2787-2796.
16. Dutrillaux B, Lejeune J. [A new technic of analysis of the human karyotype]. C R Acad Sci Hebd Seances Acad Sci D. 272:1971;2638-2640.
17. MacPherson I, Montagnier L. Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology. 23:1964;291-294.
18. Islam MQ, Islam K, Levan G, Horvath G. Monochromosome transfers to Syrian hamster BHK cells via microcell fusion provide functional evidence for suppressor genes on human chromosome 9 both for anchorage independence and for tumorigenicity. Genes Chromosomes Cancer. 13:1995;115-125.
19. Kumar C C, Prorock-Rogers C, Kelly J, Dong Z, Lin J J, Armstrong L, et al. SCH 51344 inhibits ras transformation by a novel mechanism. Cancer Res. 55:1995;5106-5117.
20. Marion M, Froment O, Trépo C. Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure. Mol Carcinog. 4:1991;450-454.
21. Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, et al. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 51:1991;4090-4096.
22. Froment O, Boivin S, Barbin A, Bancel B, Trepo C, Marion MJ. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride. Cancer Res. 54:1994;5340-5345.
23. Hollstein M, Marion M, Lehman T, Welsh J, Harris C, Martel-Planche G, et al. p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis. 15:1994;1-3.
24. van Eyken P, Sciot R, van Damme B, de Wolf-Peeters C, Desmet V J. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol. 412:1987;63-72.
25. Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest. 52:1973;2757-2764.
26. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem. 264:1989;10756-10762.
27. Li FP, Fraumeni J F. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst. 43:1969;1365-1373.
28. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, Moy EL, et al. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol. 15:1995;4745-4753.
29. Bischoff FZ, Yim SO, Pathak S, Grant G, Siciliano MJ, Giovanella BC, et al. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res. 50:1990;7979-7984.
30. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wildtype p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 70:1992;937-948.
31. Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol. 15:1995;425-432.
32. Seizinger BR, Klinger HP, Junien C, Nakamura Y, Le Beau M, Cavenee W, et al. Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet. 58:1991;1080-1096.
33. Anderson MJ, Fasching CL, Xu HJ, Benedict WF, Stanbridge EJ. Chromosome 13 transfer provides evidence for regulation of RB1 protein expression. Genes Chromosomes Cancer. 9:1994;251-260.
34. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, et al. IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res. 26:1998;205-213.
35. Soini Y, Welsh JA, Ishak KG, Bennett WP. p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposure. Carcinogenesis. 16:1995;2879-2881.
36. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature. 351:1991;453-456.
37. Rastinejad F, Polverini P, Bouck N. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell. 56:1989;345-355.
38. Dameron K, Volpert O, Tainsky M, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 265:1994;1582-1584.
39. Van Meir E, Polverini P, Chazin V, Su Huang H, De Tribolet N, Cavenee W. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet. 8:1994;171-176.
40. Pedron S, Lefrançois L, Trepo C, Marion MJ. Les myofibroblastes hépatiques stimulent la prolifération des cellules endothéliales. Gastroenterol Clin Biol. 23:1999;940.